Early Moderate Hyperoxemia Does Not Predict Outcome After Aneurysmal Subarachnoid Hemorrhage

Area of Science:

• Neurocritical Care
• Intensive Care Medicine
• Neurology

Background:

• Hyperoxemia management is standard in neurocritical care.
• The safety and impact of hyperoxemia on patient outcomes are under scrutiny.
• Aneurysmal subarachnoid hemorrhage (SAH) patients often require interventions that can affect oxygen levels.

Purpose of the Study:

• To determine the independent effect of hyperoxemia on outcomes in patients with aneurysmal subarachnoid hemorrhage (SAH).
• To analyze the association between different levels of oxygenation and patient outcomes.

Main Methods:

• Included 432 mechanically ventilated aneurysmal SAH patients.
• Calculated time-weighted averages (TWAs) of PaO2 in the first 24 hours in the ICU.
• Categorized patients into low, intermediate, and high TWA-PaO2 groups.
• Assessed unfavorable outcomes (Glasgow Outcome Scale 1-3) and mortality at 3 months using multivariate logistic regression.

Main Results:

• 53% of patients experienced an unfavorable outcome, and 28% died.
• Patients with unfavorable outcomes had higher TWA-PaO2 levels (137 mm Hg) compared to those with favorable outcomes (118 mm Hg).
• Multivariate analysis showed no significant association between TWA-PaO2 bands and unfavorable outcome or mortality.

Conclusions:

• Early moderate hyperoxemia (PaO2 levels) may not influence the risk of poor outcomes in mechanically ventilated aneurysmal SAH patients.
• The findings suggest that current oxygen targeting strategies might not need adjustment for this specific patient population.
• Further research may explore optimal oxygen thresholds in neurocritical care settings.